Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
Browse all the diagnosis codes used for coagulation defects, purpura and other hemorrhagic conditions (d65-d69). For easy navigation, the diagnosis codes are sorted in alphabetical order and grouped by sections. Each section is clearly marked with its description, and the corresponding three-digit code range. This format makes it simple to browse diagnosis codes in this chapter or section and find what you're looking for. We've also added green checkmark icons to label billable codes, and red warning icons for non-billable ones. This makes it easy to identify which codes can be billed.
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism (D50–D89)
Coagulation defects, purpura and other hemorrhagic conditions (D65-D69)
- D65 Disseminated intravascular coagulation [defibrination syndrome]
Disseminated intravascular coagulation [defibrination syndrome] (D65)
- D66 Hereditary factor VIII deficiency
Hereditary factor VIII deficiency (D66)
- D67 Hereditary factor IX deficiency
Hereditary factor IX deficiency (D67)
D68 Other coagulation defects
D68.0 Von Willebrand disease
- D68.00 Von Willebrand disease, unspecified
- D68.01 Von Willebrand disease, type 1
D68.02 Von Willebrand disease, type 2
- D68.020 Von Willebrand disease, type 2A
- D68.021 Von Willebrand disease, type 2B
- D68.022 Von Willebrand disease, type 2M
- D68.023 Von Willebrand disease, type 2N
- D68.029 Von Willebrand disease, type 2, unspecified
- D68.03 Von Willebrand disease, type 3
- D68.04 Acquired von Willebrand disease
- D68.09 Other von Willebrand disease
- D68.1 Hereditary factor XI deficiency
- D68.2 Hereditary deficiency of other clotting factors
D68.3 Hemorrhagic disorder due to circulating anticoagulants
D68.31 Hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
- D68.311 Acquired hemophilia
- D68.312 Antiphospholipid antibody with hemorrhagic disorder
- D68.318 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
- D68.32 Hemorrhagic disorder due to extrinsic circulating anticoagulants
- D68.4 Acquired coagulation factor deficiency
D68.5 Primary thrombophilia
- D68.51 Activated protein C resistance
- D68.52 Prothrombin gene mutation
- D68.59 Other primary thrombophilia
D68.6 Other thrombophilia
- D68.61 Antiphospholipid syndrome
- D68.62 Lupus anticoagulant syndrome
- D68.69 Other thrombophilia
- D68.8 Other specified coagulation defects
- D68.9 Coagulation defect, unspecified
Other coagulation defects (D68)
D69 Purpura and other hemorrhagic conditions
- D69.0 Allergic purpura
- D69.1 Qualitative platelet defects
- D69.2 Other nonthrombocytopenic purpura
- D69.3 Immune thrombocytopenic purpura
D69.4 Other primary thrombocytopenia
- D69.41 Evans syndrome
- D69.42 Congenital and hereditary thrombocytopenia purpura
- D69.49 Other primary thrombocytopenia
D69.5 Secondary thrombocytopenia
- D69.51 Posttransfusion purpura
- D69.59 Other secondary thrombocytopenia
- D69.6 Thrombocytopenia, unspecified
- D69.8 Other specified hemorrhagic conditions
- D69.9 Hemorrhagic condition, unspecified
Purpura and other hemorrhagic conditions (D69)
